Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology - Basic: Basic Science

  • You have access
    Tumor FDG uptake as biomarker for defining the optimal biological dose of the mTOR inhibitor everolimus
    C. Kuntner, Daniel Cejka, T. Wanek, Maria Zsebedics, Markus Mueller, Volker Wacheck and Oliver Langer
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 452;
  • You have access
    Evaluation of tumor response to the antivascular agent DMXAA using 18F-FMISO PET
    Christoph Oehler-Janne, Joseph O'Donoghue, C.Clifton Ling and Sean Carlin
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 451;
  • You have access
    Radioimmunotherapy of small peritoneal carcinomatosis using 125I-labeled monoclonal antibodies
    Jean-Pierre Pouget, Lore Santoro, Berengere Piron, Samir Boutaleb, Caroline Bascoul-Mollevi, Manuel Bardies, Pierre-Olivier Kotzki, Monique Pelegrin and Andre Pelegrin
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 505;
  • You have access
    Development of a Ga-68-labelled gastrin-based PET tracer for the detection of CCK2/gastrin receptor positive neuroendocrine tumors
    Maarten Brom, Lieke Joosten, Wim Oyen, Otto Boerman and M. Gotthardt
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 387;
  • You have access
    A protein scaffold based molecule for EGFR PET imaging
    Zheng Miao, Gang Ren, Hongguang Liu, Lei Jiang, Zhen Cheng and Sanjiv Gambhir
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 386;
  • You have access
    18F-Labeled C2A domain of synaptotagmin I and 18F-labeled recombinant human His10-annexin V as two potential PET tracers for the detection of cell death
    Feng Wang, Zizheng Wang and Wei Qu
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 385;
  • You have access
    Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin
    Gabie De jong, Thijs Hendriks, Wim Oyen, Sandra Heskamp, Annemarie Eek, Robert Bleichrodt and Otto Boerman
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 504;
  • You have access
    Apoptosis imaging with PET-18F-ML-10 for early assessment of response of brain metastases to radiotherapy
    Anat Shirvan, Ayelet Reshef, Aaron Allen, Eyal Fenig, Adam Steinmetz, David Groshar, Eyal Mishani and Ilan Ziv
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 453;
  • You have access
    Non-invasive PET imaging of downregulation of HER-2 in 17-DMAG treated ovarian cancers
    Gang Niu, Zibo Li and Xiaoyuan (Shawn) Chen
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 455;
  • You have access
    Genetic background differences in murine hepatic retention of 64Cu-ATSM is associated with differential expression of multidrug resistance protein 3
    Jun Liu, Asghar Hajibeigi, Mai Lin, Xiankai Sun and Orhan K. Oz
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 273;

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire